Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 24:3:2050312114568476.
doi: 10.1177/2050312114568476. eCollection 2015.

Autonomic dysfunction independently predicts poor cardiovascular outcomes in asymptomatic individuals with type 2 diabetes in the DIAD study

Deborah A Chyun  1 , Frans J Th Wackers  2 , Silvio E Inzucchi  3 , Powell Jose  4 , Curtis Weiss  5 , Janice A Davey  3 , Gary V Heller  6 , Ami E Iskandrian  7 , Lawrence H Young  2 ; DIAD Investigators
Affiliations

Autonomic dysfunction independently predicts poor cardiovascular outcomes in asymptomatic individuals with type 2 diabetes in the DIAD study

Deborah A Chyun et al. SAGE Open Med. .

Abstract

Objective: The primary aim of this secondary analysis was to determine whether cardiac autonomic neuropathy independently predicted adverse cardiac outcomes in asymptomatic individuals with type 2 diabetes. Additional aims include the determination of the correlation of standard autonomic testing measures and power spectral analysis of heart rate variability, and the association of diabetes-related and cardiac risk factors with cardiac autonomic neuropathy measures.

Methods: Cardiac autonomic neuropathy was assessed at the study entry into the Detection of Ischemia in Asymptomatic Diabetics study, using autonomic heart rate and blood pressure testing, and power spectral analysis of heart rate variability. All participants were prospectively followed for the composite clinical outcome of cardiac death, acute coronary syndromes, heart failure, or coronary revascularization.

Results: Over 5 years of follow-up, 94 of 1119 (8.4%) subjects developed symptomatic cardiac disease. In unadjusted bivariate analyses, abnormalities in several cardiac autonomic neuropathy tests, including lower Valsalva and Standing Heart Rate Ratios, higher resting Heart Rate, greater systolic blood pressure decrease on standing, and lower low-frequency power, were predictive of symptomatic disease. Independent predictors of poor cardiac outcome were a lower Valsalva Heart Rate Ratio, non-Black ethnicity, longer diabetes duration, higher glycated hemoglobin (HbA1c), insulin use, reported numbness in the extremities, higher pulse pressure, family history of coronary artery disease, and higher waist-to-hip ratio. Clinical factors independently associated with a lower Valsalva Heart Rate Ratio were insulin use, clinical proteinuria, higher pulse pressure, use of angiotensin-converting enzyme inhibitor and non-Black ethnicity.

Conclusion: Cardiac autonomic neuropathy predicted adverse cardiac outcomes in asymptomatic type 2 diabetes without known cardiac disease. Clinical variables may help to identify patients who might have cardiac autonomic neuropathy and warrant consideration for autonomic testing.

Keywords: Type 2 diabetes; asymptomatic myocardial ischemia; cardiac autonomic neuropathy; pulse pressure.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: DIAD is an investigator-initiated study. The industrial sponsors had no role in the design or conduct of the study, in the collection, analysis or interpretation of data, or in the preparation of the manuscript.

References

    1. Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med 2014; 370: 1514–1523. - PubMed
    1. Jouven X, Lemaitre RN, Rea TD, et al. Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J 2005; 26: 2142–2147. - PubMed
    1. Young L, Wackers F, Chyun D, et al. Cardiac outcomes after screening for coronary artery disease in patients with type 2 diabetes: the DIAD Study: A Randomized Controlled Trial. JAMA 2009; 301: 1547–1555. - PMC - PubMed
    1. Kahn R, Robertson RM, Smith R, et al. The impact of prevention on reducing the burden of cardiovascular disease. Circulation 2008; 118: 576–585. - PubMed
    1. Wackers FJT, Young LH, Inzucchi SE, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD Study. Diabetes Care 2004; 27: 1954–1961. - PubMed

LinkOut - more resources